Cargando…
Increased tumour dihydroceramide production after Photofrin-PDT alone and improved tumour response after the combination with the ceramide analogue LCL29. Evidence from mouse squamous cell carcinomas
Photodynamic therapy (PDT) has been proven effective for treatment of several types of cancer. Photodynamic therapy alone, however, attains limited cures with some tumours and there is need for its improved efficacy in such cases. Sphingolipid (SL) analogues can promote tumour response in combinatio...
Autores principales: | Separovic, D, Bielawski, J, Pierce, J S, Merchant, S, Tarca, A L, Ogretmen, B, Korbelik, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653738/ https://www.ncbi.nlm.nih.gov/pubmed/19223911 http://dx.doi.org/10.1038/sj.bjc.6604896 |
Ejemplares similares
-
Mitochondrially targeted ceramide LCL-30 inhibits colorectal cancer in mice
por: Dahm, F, et al.
Publicado: (2008) -
Distribution of Photofrin between tumour cells and tumour associated macrophages.
por: Korbelik, M., et al.
Publicado: (1991) -
Photofrin accumulation in malignant and host cell populations of various tumours.
por: Korbelik, M., et al.
Publicado: (1996) -
Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy.
por: Krosl, G., et al.
Publicado: (1995) -
Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours
por: Korbelik, M, et al.
Publicado: (2003)